LT3167882T - Fenofibrato arba jo darinio naudojimas diabetinės retinopatijos prevencijai - Google Patents

Fenofibrato arba jo darinio naudojimas diabetinės retinopatijos prevencijai

Info

Publication number
LT3167882T
LT3167882T LTEP16185410.4T LT16185410T LT3167882T LT 3167882 T LT3167882 T LT 3167882T LT 16185410 T LT16185410 T LT 16185410T LT 3167882 T LT3167882 T LT 3167882T
Authority
LT
Lithuania
Prior art keywords
fenofibrate
derivative
diabetic retinopathy
preventing diabetic
preventing
Prior art date
Application number
LTEP16185410.4T
Other languages
English (en)
Inventor
Jean-Claude Ansquer
Anthony Keech
Original Assignee
Bgp Products Operations Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36130110&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT3167882(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bgp Products Operations Gmbh filed Critical Bgp Products Operations Gmbh
Publication of LT3167882T publication Critical patent/LT3167882T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
LTEP16185410.4T 2005-11-10 2006-11-10 Fenofibrato arba jo darinio naudojimas diabetinės retinopatijos prevencijai LT3167882T (lt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP05292388A EP1785133A1 (en) 2005-11-10 2005-11-10 Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy

Publications (1)

Publication Number Publication Date
LT3167882T true LT3167882T (lt) 2020-07-27

Family

ID=36130110

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP16185410.4T LT3167882T (lt) 2005-11-10 2006-11-10 Fenofibrato arba jo darinio naudojimas diabetinės retinopatijos prevencijai

Country Status (18)

Country Link
US (1) US20090170939A1 (lt)
EP (3) EP1785133A1 (lt)
JP (1) JP5171635B2 (lt)
KR (1) KR20080074877A (lt)
CN (2) CN103417524A (lt)
AU (1) AU2006313711B2 (lt)
BR (1) BRPI0618283A2 (lt)
CA (1) CA2628508C (lt)
EA (1) EA014755B1 (lt)
ES (2) ES2605025T3 (lt)
HU (2) HUE050045T2 (lt)
IL (1) IL191208A (lt)
LT (1) LT3167882T (lt)
PL (2) PL1954261T3 (lt)
PT (2) PT1954261T (lt)
SI (1) SI3167882T1 (lt)
UA (1) UA99093C2 (lt)
WO (1) WO2007054566A2 (lt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102304103A (zh) * 2011-06-03 2012-01-04 郑州泰基鸿诺药物科技有限公司 一种非诺贝特酸盐、制备方法、药物组合物及应用
AU2014339890A1 (en) * 2013-10-25 2016-06-02 Children's Medical Center Corporation Methods of treating or preventing vascular diseases of the retina

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2494112B1 (lt) 1980-11-19 1986-01-10 Laruelle Claude
FR2602423B1 (fr) 1986-08-08 1989-05-05 Ethypharm Sa Procede de preparation d'un medicament a base de fenofibrate, medicament obtenu par ce procede
FR2627696B1 (fr) 1988-02-26 1991-09-13 Fournier Innovation Synergie Nouvelle forme galenique du fenofibrate
CA2052014A1 (en) * 1990-10-19 1992-04-20 Henry Y. Pan Method for preventing diabetic complications employing a cholesterol lowering drug alone or in combination with an ace inhibitor
SI9500173B (sl) 1995-05-19 2002-02-28 Lek, Trofazna farmacevtska oblika s konstantnim in kontroliranim sproščanjem amorfne učinkovine za enkrat dnevno aplikacijo
DE19608750A1 (de) 1996-03-06 1997-09-11 Durachemie Gmbh & Co Kg Verfahren zur Herstellung von Fenofibrat-Präparaten
FR2758459B1 (fr) 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6465011B2 (en) 1999-05-29 2002-10-15 Abbott Laboratories Formulations comprising lipid-regulating agents
JPWO2002030425A1 (ja) * 2000-10-12 2004-02-19 日産化学工業株式会社 糖尿病合併症予防・治療剤
MXPA03003733A (es) * 2000-10-26 2004-10-15 Fournier Lab Ireland Ltd Combinacion de fenofibrato y coenzima q10 para el tratamiento de la disfuncion endotelial.
US6534088B2 (en) 2001-02-22 2003-03-18 Skyepharma Canada Inc. Fibrate-statin combinations with reduced fed-fasted effects
JP4590159B2 (ja) * 2001-04-04 2010-12-01 オーソ−マクニール・フアーマシユーチカル・インコーポレーテツド グルコース再吸収阻害剤およびｐｐａｒモジュレーターを含んで成る併用療法
PT1572196E (pt) * 2002-12-10 2008-11-20 Novartis Ag Combinação de um inibidor da dpp-iv e um composto ppar alfa
US7259186B2 (en) 2002-12-17 2007-08-21 Abbott Laboratories Salts of fenofibric acid and pharmaceutical formulations thereof
WO2004066963A2 (en) * 2003-01-17 2004-08-12 Merck & Co., Inc. N-cyclohexylaminocarbonyl benzenesulfonamide derivatives
US20070197602A1 (en) * 2004-02-09 2007-08-23 Hashime Kanazawa Combined pharmaceutical composition

Also Published As

Publication number Publication date
IL191208A0 (en) 2009-08-03
CN103417524A (zh) 2013-12-04
HUE050045T2 (hu) 2020-11-30
EP1954261B1 (en) 2016-08-24
EP3167882B1 (en) 2020-04-08
PL3167882T3 (pl) 2020-11-16
IL191208A (en) 2017-08-31
EP3167882A1 (en) 2017-05-17
ES2805227T3 (es) 2021-02-11
PT3167882T (pt) 2020-07-13
US20090170939A1 (en) 2009-07-02
EA200801023A1 (ru) 2008-10-30
UA99093C2 (ru) 2012-07-25
EA014755B1 (ru) 2011-02-28
JP2009515856A (ja) 2009-04-16
CA2628508C (en) 2013-11-12
CA2628508A1 (en) 2007-05-18
WO2007054566A2 (en) 2007-05-18
CN101304742A (zh) 2008-11-12
AU2006313711A9 (en) 2021-04-01
EP1954261A2 (en) 2008-08-13
JP5171635B2 (ja) 2013-03-27
HUE030936T2 (en) 2017-06-28
PT1954261T (pt) 2016-11-29
BRPI0618283A2 (pt) 2012-02-28
WO2007054566A3 (en) 2007-08-23
PL1954261T3 (pl) 2017-07-31
KR20080074877A (ko) 2008-08-13
ES2605025T3 (es) 2017-03-10
SI3167882T1 (sl) 2020-09-30
EP1785133A1 (en) 2007-05-16
AU2006313711A1 (en) 2007-05-18
AU2006313711B2 (en) 2012-02-23

Similar Documents

Publication Publication Date Title
IL189212A0 (en) Therapeutic agent for diabetes
EP1880700A4 (en) DISPOSABLE LAYER
PL2094173T3 (pl) Jednorazowa rękojeść do witrektomii
IL224109A (en) Isoxazole derivatives for use as fungicides
EP2105115A4 (en) DISPOSABLE LAYER
EP1990034A4 (en) DISPOSABLE LAYER
IL192369A0 (en) Therapeutic agent for diabetes
IL193159A0 (en) Pyridin-4- ylmethylamides for combating pests
EG25359A (en) Disposable diaper.
EP2067459A4 (en) DISPOSABLE DIAPERS
TWI368497B (en) Disposable diaper
IL197714A0 (en) 2-pyridinecarboxamide derivative having gk-activating activity
IL240118A0 (en) Biological glue without thrombin and its use as a medicine
EP1917944A4 (en) DISPOSABLE LAYER
EP2027840A4 (en) DISPOSABLE LAYER
IL195355A0 (en) Substituted pyrazinone derivatives for use as a medicine
PT1693027E (pt) Ponta de facoemulsificação
IL191208A0 (en) Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
AU2006313711A2 (en) Use of fenofibrate or a derivative thereof for preventing diabetic retinopathy
HK1114023A (en) Use of fenofibrate or a derivative thereof for treating diabetic retinopathy
HUP0600409A3 (en) Izatin and it's derivatives for use as a medicine
EP1927353A4 (en) MEANS FOR THE TREATMENT OF CORNEAL DISEASES
EP1894589A4 (en) SELF-DESTROYING INJECTION SYRINGE
ZA200806143B (en) Therapeutic agent for diabetes
HK1118018A (en) Therapeutic agent for diabetes